IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced an expansion of its…

Roche pays $55M upfront to Manifold Bio in new research deal for better brain shuttles

As Roche kicks off Phase 3 studies for its "Brainshuttle" Alzheimer's drug, it's also hunting for the next best way to get drugs into the brain. On Monday, the Swiss pharma company announced a research ...

WSAI & Ohio State University researchers develop new AI framework to fast track drugs discovery

Researchers from IIT Madras’ Wadhwani School of Data Science and Artificial Intelligence (WSAI) and The Ohio State University, U.S., have developed a breakthrough Artificial Intelligence framework that can rapidly generate drug-like molecules that are easier to synthesise in real-world laboratory settings. The system promises to significantly cut down the early-stage timelines of drug development — currently a billion-dollar, decade-long process…